• LinkedIn
  • Twitter
Vesigen Therapeutics
  • About
    • Company Overview
    • Team
    • Investors
  • Our Science
  • Programs
  • News
  • Careers
  • Contact
  • Menu Menu
  • About
    • Company Overview
    • Team
    • Investors
  • Our Science
  • Programs
  • News
  • Careers
  • Contact

About

Our mission: design, discover and deliver new medicines

Our purpose: delivering tomorrow’s precision medicine

More than 80 percent of validated therapeutic targets are intracellular. Drugging these targets is complicated by the significant barriers to delivery, including cell membranes and degradative systems, which have largely restricted existing intracellular therapies to small molecule drugs

Driven by a critical need

We recognize the need to develop novel approaches to package therapeutic agents to enable direct transfer into cells to access targets, while avoiding immune reaction and degradation mechanisms that interfere with successful delivery. This treatment gap drives Vesigen’s development of our novel ARMMs (ARRDC1 Mediated Microvesicles) technology, a class of extracellular vesicles that permits novel therapeutic paradigms in hard-to-access tissue types.

Advancing therapeutic opportunity

With a seasoned team, we intend to expediently advance our portfolio and to chart a clear path to the clinic . Our team has decades of experience leading drug discovery and development activities in preclinical and clinical settings. Supported by our top-tier investors and a prominent scientific advisory board, Vesigen is prepared to deliver on the promise of ARMMed therapeutics.

Join our team

Explore current opportunities

  • About
  • Our Science
  • Programs
  • News
  • Careers
  • Contact

Vesigen Therapeutics
790 Memorial Drive
Suite 103
Cambridge, MA 02139

LinkeInTwitter

© 2020 Vesigen Therapeutics
All rights reserved.
Privacy Policy
Terms of Use

Design and development by RainCastle Communications
Scroll to top
  • About
    • Company Overview
    • Team
    • Investors
  • Our Science
  • Programs
  • News
  • Careers
  • Contact